BBA
GILD icon

Baader Bank Aktiengesellschaft’s Gilead Sciences GILD Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-30,000
Closed -$1.85M – 389
2022
Q3 		$1.85M Buy
+30,000
New +$1.89M 0.12% 159
2022
Q2 		– Sell
-2,000
Closed -$119K – 357
2022
Q1 		$119K Buy
+2,000
New +$128K 0.01% 240

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Baader Bank Aktiengesellschaft's GILD Position: Q2 2026 in Review

Baader Bank Aktiengesellschaft increased its Gilead Sciences (GILD) stake by 44% in Q2 2026, buying an estimated $481K and bringing the position to 11,970 shares worth $1.51M. The position accounts for 0.11% of the portfolio, ranked #146.

Baader Bank Aktiengesellschaft first reported a position in GILD in Q4 2021 and has held it in 13 quarters since. The position peaked at $9.35M in Q4 2021. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Baader Bank Aktiengesellschaft held 11,970 shares of Gilead Sciences worth $1.51M as of Q2 2026.
  • Baader Bank Aktiengesellschaft bought 3,650 Gilead Sciences shares in Q2 2026, an estimated $481K.
  • Gilead Sciences made up 0.11% of Baader Bank Aktiengesellschaft's portfolio in Q2 2026, its #146 holding.
  • Baader Bank Aktiengesellschaft first reported a position in Gilead Sciences in Q4 2021 and has held it in 13 quarters since.
  • Baader Bank Aktiengesellschaft's Gilead Sciences position peaked at $9.35M in Q4 2021.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2026, filed 23 Jul 2026.